HK inno.N Corporation (KOSDAQ:195940)

South Korea flag South Korea · Delayed Price · Currency is KRW
46,100
+1,100 (2.44%)
Aug 8, 2025, 3:30 PM KST
2.44%
Market Cap1.27T
Revenue (ttm)839.63B
Net Income (ttm)41.49B
Shares Out28.33M
EPS (ttm)1,451.65
PE Ratio31.00
Forward PE15.96
Dividend350.00 (0.77%)
Ex-Dividend DateMar 28, 2025
Volume2,181,271
Average Volume226,483
Open52,600
Previous Close45,000
Day's Range45,650 - 53,100
52-Week Range31,650 - 52,000
Beta0.69
RSI58.38
Earnings DateJul 28, 2025

About Activision Blizzard

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, no... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 1,695
Stock Exchange KOSDAQ
Ticker Symbol 195940
Full Company Profile

Financial Performance

In 2021, HK inno.N's revenue was 769.79 billion, an increase of 28.63% compared to the previous year's 598.45 billion. Earnings were 21.35 billion, a decrease of -23.49%.

Financial Statements

News

There is no news available yet.